• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局限性肾细胞癌患者其他原因死亡的预测因素

Predicting factors for death from other causes in patients with localized renal cell carcinoma.

作者信息

Chang Jin Suk, Park Yong Hyun, Ku Ja Hyun, Kwak Cheol, Kim Hyeon Hoe

机构信息

Department of Urology, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Korean J Urol. 2012 Jan;53(1):18-22. doi: 10.4111/kju.2012.53.1.18. Epub 2012 Jan 25.

DOI:10.4111/kju.2012.53.1.18
PMID:22323969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3272551/
Abstract

PURPOSE

To identify the predictors of death from other causes in patients with localized renal cell carcinoma (RCC).

MATERIALS AND METHODS

We identified 1,101 patients with pathologically confirmed T1 or T2 RCC with a follow-up duration of over 6 months. Survival according to the cause of death was evaluated by using the Kaplan-Meier analysis with log-rank test. Prognostic factors for death from other causes were assessed by multivariate analysis using the Cox proportional hazard regression model. Once the prognostic factors were identified, a risk-group variable was created by counting the number of unfavorable features present for each patient.

RESULTS

The median follow-up was 62 months, and RCC-related death occurred in 50 patients (4.5%), whereas death from other causes occurred in 47 (4.3%). Patients who died from other causes had a higher American Society of Anesthesiologist (ASA) score (26.1% vs. 10.2%; p=0.044), older age (63.4 years vs. 55.0 years; p<0.001), smaller mass size (5.1 cm vs. 7.9 cm; p<0.001), and lower nuclear grade (p=0.003). In the multivariate Cox regression analysis, older age, higher ASA score, and lower body mass index were independent factors predicting death from other causes in patients with localized RCC. On the basis of the number of risk factors for death from other causes, the 5-year other-cause-specific survival was 98.3% (0 risk factors), 84.7% (1 risk factor), and 67.6% (2 or 3 risk factors), respectively (p<0.001).

CONCLUSIONS

Older age, higher ASA score, and lower body mass index were independent predictors of death from other causes in patients with localized RCC.

摘要

目的

确定局限性肾细胞癌(RCC)患者因其他原因死亡的预测因素。

材料与方法

我们纳入了1101例经病理证实为T1或T2期RCC且随访时间超过6个月的患者。采用Kaplan-Meier分析和对数秩检验评估按死亡原因的生存率。使用Cox比例风险回归模型通过多变量分析评估因其他原因死亡的预后因素。一旦确定了预后因素,通过计算每位患者存在的不良特征数量创建一个风险组变量。

结果

中位随访时间为62个月,50例患者(4.5%)发生RCC相关死亡,而47例(4.3%)因其他原因死亡。因其他原因死亡的患者美国麻醉医师协会(ASA)评分更高(26.1%对10.2%;p = 0.044)、年龄更大(63.4岁对55.0岁;p<0.001)、肿块尺寸更小(5.1 cm对7.9 cm;p<0.001)且核分级更低(p = 0.003)。在多变量Cox回归分析中,年龄较大、ASA评分较高和体重指数较低是局限性RCC患者因其他原因死亡的独立预测因素。根据因其他原因死亡的风险因素数量,5年其他原因特异性生存率分别为98.3%(0个风险因素)、84.7%(1个风险因素)和67.6%(2个或3个风险因素)(p<0.001)。

结论

年龄较大、ASA评分较高和体重指数较低是局限性RCC患者因其他原因死亡的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f2/3272551/a4f3a6e4f957/kju-53-18-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f2/3272551/3a22cf94a99d/kju-53-18-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f2/3272551/956a41e1c02e/kju-53-18-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f2/3272551/a4f3a6e4f957/kju-53-18-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f2/3272551/3a22cf94a99d/kju-53-18-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f2/3272551/956a41e1c02e/kju-53-18-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f2/3272551/a4f3a6e4f957/kju-53-18-g003.jpg

相似文献

1
Predicting factors for death from other causes in patients with localized renal cell carcinoma.局限性肾细胞癌患者其他原因死亡的预测因素
Korean J Urol. 2012 Jan;53(1):18-22. doi: 10.4111/kju.2012.53.1.18. Epub 2012 Jan 25.
2
Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.乳头状(嗜色性)肾细胞癌:62例的组织形态学特征及传统病理预后参数评估
Am J Surg Pathol. 1997 Jun;21(6):621-35. doi: 10.1097/00000478-199706000-00001.
3
Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?在 CORONA 项目的一项综合多中心研究中评估肾细胞癌患者 pT1-pT3a 局限性肿瘤中肾周脂肪侵犯和肿瘤大小的预后意义。我们能否改善 pT3a 期肿瘤患者的预后判别?
Eur Urol. 2015 May;67(5):943-51. doi: 10.1016/j.eururo.2014.11.055. Epub 2015 Feb 13.
4
Impact of rhabdoid differentiation on postoperative outcome for patients with N0M0 renal cell carcinoma.横纹肌样分化对 N0M0 肾细胞癌患者术后结局的影响。
Urol Oncol. 2019 Oct;37(10):711-720. doi: 10.1016/j.urolonc.2019.05.012. Epub 2019 Jun 5.
5
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.嫌色细胞肾细胞癌(RCC):大型多中心系列中的肿瘤学结果和预后因素。
BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.
6
A novel prognostic model for patients with sarcomatoid renal cell carcinoma.一种用于肉瘤样肾细胞癌患者的新型预后模型。
BJU Int. 2015 Mar;115(3):405-11. doi: 10.1111/bju.12781. Epub 2014 Oct 19.
7
pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.pT1期透明细胞肾细胞癌:MIB-1增殖活性与病理特征及癌症特异性生存之间的关联研究
Cancer. 2002 Apr 15;94(8):2180-4. doi: 10.1002/cncr.10433.
8
Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.小而局限于器官的肾细胞癌(RCC)的长期预后并不总是良好的。
BJU Int. 2013 May;111(6):941-5. doi: 10.1111/j.1464-410X.2012.11771.x. Epub 2013 Jan 25.
9
Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters.肿瘤大小对局限性传统型(透明细胞)肾细胞癌的预后重要性:TNM T1和T2肿瘤类别的评估以及与其他预后参数的比较。
Cancer. 2002 Feb 1;94(3):658-64. doi: 10.1002/cncr.10255.
10
Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.利用综合列线图评估局限性肾细胞癌患者的总生存和死亡竞争风险。
J Clin Oncol. 2010 Jan 10;28(2):311-7. doi: 10.1200/JCO.2009.22.4816. Epub 2009 Nov 23.

引用本文的文献

1
Prognostic Significance of Advanced Age in Patients with T1a Renal Cell Carcinoma Treated by Microwave Ablation: A 16-Year Experience.高级年龄在微波消融治疗 T1a 肾细胞癌患者中的预后意义:16 年经验。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231183585. doi: 10.1177/15330338231183585.
2
Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study.T1N0M0期肾细胞癌幸存者的特定病因死亡率:一项基于登记处的队列研究
Front Oncol. 2021 Mar 10;11:604724. doi: 10.3389/fonc.2021.604724. eCollection 2021.
3
Prognostic indicators of pulmonary metastasis in patients with renal cell carcinoma who have undergone radical nephrectomy.

本文引用的文献

1
Association between body-mass index and risk of death in more than 1 million Asians.超过 100 万亚洲人身体质量指数与死亡风险的关联。
N Engl J Med. 2011 Feb 24;364(8):719-29. doi: 10.1056/NEJMoa1010679.
2
Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma.内脏肥胖对肾细胞癌患者肿瘤学结局的影响。
Urol Int. 2010;85(1):30-6. doi: 10.1159/000318988. Epub 2010 Jul 26.
3
Small renal masses: current concepts regarding the natural history and reflections on the American Urological Association guidelines.
接受根治性肾切除术后的肾细胞癌患者肺转移的预后指标。
Oncol Lett. 2019 Mar;17(3):3009-3016. doi: 10.3892/ol.2019.9912. Epub 2019 Jan 9.
4
Differences in peritumoral pseudocapsule characteristics according to clinicopathological factors in clinical T1a renal tumors.临床T1a期肾肿瘤中肿瘤周围假包膜特征根据临床病理因素的差异
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11323-31. eCollection 2015.
5
Influence of body mass index, smoking, and blood pressure on survival of patients with surgically-treated, low stage renal cell carcinoma: a 14-year retrospective cohort study.体重指数、吸烟和血压对低分期肾细胞癌手术治疗患者生存的影响:一项 14 年回顾性队列研究。
J Korean Med Sci. 2013 Feb;28(2):227-36. doi: 10.3346/jkms.2013.28.2.227. Epub 2013 Jan 29.
6
Renal Cell Carcinoma Update: News from the AUA, EAU, and ASCO Annual Meetings 2011.肾细胞癌最新进展:来自2011年美国泌尿外科学会(AUA)、欧洲泌尿外科学会(EAU)和美国临床肿瘤学会(ASCO)年会的消息
ISRN Urol. 2012;2012:748235. doi: 10.5402/2012/748235. Epub 2012 Jun 10.
小肾肿瘤:自然病史的当前概念及对美国泌尿外科学会指南的反思。
Curr Opin Urol. 2010 Mar;20(2):105-10. doi: 10.1097/MOU.0b013e32833625f8.
4
Prognostic value of body mass index in Korean patients with renal cell carcinoma.体重指数在韩国肾细胞癌患者中的预后价值。
J Urol. 2010 Feb;183(2):448-54. doi: 10.1016/j.juro.2009.10.004. Epub 2009 Dec 14.
5
Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.利用综合列线图评估局限性肾细胞癌患者的总生存和死亡竞争风险。
J Clin Oncol. 2010 Jan 10;28(2):311-7. doi: 10.1200/JCO.2009.22.4816. Epub 2009 Nov 23.
6
Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma.超重与器官局限性肾细胞癌患者的癌症特异性生存率提高相关。
J Cancer Res Clin Oncol. 2009 Dec;135(12):1693-9. doi: 10.1007/s00432-009-0616-2. Epub 2009 Jun 20.
7
Speakable and unspeakable facts about BMI and mortality.关于体重指数与死亡率的可及与不可及的事实
Lancet. 2009 Mar 28;373(9669):1055-6. doi: 10.1016/S0140-6736(09)60628-0.
8
Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.切除、消融还是观察:小肾肿物的困境——一项荟萃分析与综述
J Urol. 2008 Apr;179(4):1227-33; discussion 1233-4. doi: 10.1016/j.juro.2007.11.047. Epub 2008 Feb 20.
9
Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.根据查尔森合并症指数对透明细胞肾细胞癌进行生存分析。
J Urol. 2008 Mar;179(3):857-61. doi: 10.1016/j.juro.2007.10.048. Epub 2008 Jan 25.
10
Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis.肾癌手术治疗后的五年生存率:基于人群的竞争风险分析
Cancer. 2007 May 1;109(9):1763-8. doi: 10.1002/cncr.22600.